Issues in biomarker identification, validation and development for disease diagnostics in Public Health

Expert Rev Mol Diagn. 2016;16(4):383-6. doi: 10.1586/14737159.2016.1133300. Epub 2016 Jan 22.

Authors

Karen E Kempsell¹, Graham Ball², Tamas Szakmany^{3

4}

Affiliations

¹ a Diagnostic Technologies Group, Infection Services , Health Protection Agency Porton , Salisbury , Wiltshire , UK.
² b School of Science and Technology , Nottingham Trent University , Nottingham , UK.
³ c Department of Anaesthesia, Intensive Care and Pain Medicine , Cardiff University, Heath Park Campus , Cardiff , UK.
⁴ d Department of Anaesthesia and Critical Care, Royal Gwent Hospital , Aneurin Bevan University Health Board , Newport , UK.

PMID: 26680111
DOI: 10.1586/14737159.2016.1133300

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers*
Humans
Mass Screening / economics
Mass Screening / methods*
Mass Screening / standards
Molecular Diagnostic Techniques / economics
Molecular Diagnostic Techniques / methods
Molecular Diagnostic Techniques / standards
Validation Studies as Topic*

Substances

Biomarkers